3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
11
Neoplasms
2
Mycosis Fungoides
2
Squamous Cell Carcinoma of Head and Neck
1
Sezary Syndrome
1
Mesothelioma, Malignant
1
Melanoma
1
Lymphomatoid Papulosis
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cyclophosphamide
17
Cytarabine
11
venetoclax
9
fludarabine
9
Mycophenolic Acid
8
Busulfan
7
fludarabine phosphate
6
Whole-Body Irradiation
6
ruxolitinib
5
Tacrolimus
5
Methotrexate
5
Daunorubicin
5
Cyclosporine
5
Azacitidine
5
ponatinib
4
Vincristine
4
Rituximab
4
Peripheral Blood Stem Cell Transplantation
4
Etoposide
4
Dexamethasone
4
blinatumomab
3
asciminib
3
Prednisone
3
Mercaptopurine
3
Inotuzumab Ozogamicin
3
Doxorubicin
3
revumenib
2
quizartinib
2
pegfilgrastim
2
pegaspargase
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia
×
Brentuximab Vedotin
×
90 days
×
Clear all
No trials found.